Colorectal Neoplasms Clinical Trial
— PHIITOfficial title:
Preoperative High Intensity Interval Training in Patients Scheduled for Colorectal and Thoracic Surgery: The PHIIT Trial
| Verified date | May 2017 |
| Source | University of Dublin, Trinity College |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Colorectal and thoracic surgical patients are susceptible to poor postoperative outcome
including complications, mortality and increased length of stay. Preoperative physical
fitness is protective against poor postoperative outcome in intra-abdominal and thoracic
surgery.
The current colorectal/thoracic pathway from diagnosis to surgery is about 2 weeks and
therefore interventions of longer duration are not feasible. Clinicians may be presented
with a difficult choice in delaying surgery to perform prehab or cancel the pre-op
intervention.
To create greater improvements in aerobic fitness, participants are required to exercise at
high levels of VO2peak (e.g. ≥80% VO2peak). High intensity interval training (HIIT) requires
participants to exercise at high levels of VO2peak (≥80% VO2peak) for short periods (e.g. 15
seconds) followed by a recovery (active or passive) and typically continue this pattern for
30 minutes or until exhaustion.
HIIT programmes are safe and a recent meta-analysis noted that HIIT produced a more
pronounced incremental gain in participants' mean VO2peak when compared with continuous
moderate intensity exercise (+1.78mL/kg/min, 95% CI: 0.45-3.11).
HITT has not been investigated as a preoperative intervention to either optimize fitness
prior to surgery or reduce post-surgical complications. Preoperative HIIT is an intense
intervention which will require significant participant adherence. The safety, cost and
clinical application of such a programme needs to be performed. This feasibility study aims
to assess the ability of HIIT to improve aerobic fitness two weeks prior to surgery and
determine its feasibility.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 2016 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Patients scheduled for colorectal or thoracic surgery 2. Able to give informed consent 3. Ability to understand English Exclusion Criteria: - Acute myocardial infarction - Unstable angina - Uncontrolled arrhythmias causing symptoms or hemodynamic compromise - Syncope - Active endocarditis - Symptomatic severe aortic stenosis - Uncontrolled heart failure - Acute pulmonary embolous or pulmonary infarction - Thrombosis of lower extremities - Suspected dissecting aneurysm - Uncontrolled asthma - Pulmonary edema - Room air desaturation at rest =85% - Respiratory failure - Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise (i.e. infection, renal failure, thyrotoxicosis) - Cognitive impairment leading to inability to cooperate - Left main coronary stenosis or equivalent - Moderate stenotic valvular heart disease - Severe untreated arterial hypertension at rest (>200 mmHg systolic, >120 mmHg diastolic) - Tachyarrhythmias or bradyarrhythmias - High-degree atrioventricular block - Hypertrophic cardiomyopathy - Significant pulmonary hypertension - Pregnancy - Electrolyte abnormalities - Orthopaedic impairment that compromises exercise performance - Individuals with pacemakers or defibrillators - Epilepsy - Past history or MRI evidence of brain damage, including significant trauma, stroke, transient ischaemic attack (TIA), hydrocephalus, mental retardation, or serious neurological disorder - Non resectable disease - Emergency surgery |
| Country | Name | City | State |
|---|---|---|---|
| Ireland | St. James's Hospital | Dublin |
| Lead Sponsor | Collaborator |
|---|---|
| University of Dublin, Trinity College |
Ireland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Cost | The cost of the programme will be recorded. Expected costs include, parking, room rental charges, equipment rates, employee rates. | 6 months | |
| Primary | Adherence/Compliance | The adherence rates will be measured by recording the number of appointments each participant attends. The number of missed sessions per participant and the reasons for missing sessions will be recorded and reported. If a participant misses an exercise sessions they will be contacted by the research team to determine the reason and to reschedule the class for later that day if possible. If a participant misses more than 50% of total exercise sessions in the absence of a defined reason (acute illness or scheduled holiday), it will be recorded as a protocol violation. |
6 months | |
| Primary | Incidence of Adverse Events | Adverse events will be assessed at every clinic visit and the following details recorded: type, incidence, severity, timing, seriousness, and relatedness to a) disease and b) the intervention. | 6 months | |
| Primary | Satisfaction/Acceptability | Self-administered questionnaire on completion of programme will be administered. Participants will also be asked to highlight what they liked and didn't like about the programme and any suggestions for change. | 6 months | |
| Primary | Withdrawal of participants | Participants are free to withdraw from the trial at any stage without providing a reason and without consequence. This information will be stated in the participant information leaflet. Participants can inform the research team at their local site of their decision to withdraw. If a participant withdraws from the study, any data collected on them up to that point in the study will go forward for study analysis. This information will be stated in the participant information leaflet. If a participant withdraws from the intervention, but provides consent to complete subsequent follow-up measurements they will continue to attend study assessments and data will be used for intention-to-treat analysis. Participants will be asked for their reason to withdrawing consent, participants are not required to give a reason. Reasons for stopping the intervention will be recorded and reported | 6 months | |
| Primary | Protocol deviations/Adaptations | The following deviations will be recorded and reported. • Changes to exercise protocol (e.g. reduction in number of sessions, change in % PPO performed during exercise session) |
6 months | |
| Primary | Compliance | Compliance will be measured in the percentage of exercise sessions attended and successfully completed. | 6 months | |
| Secondary | Postoperative mortality | Postoperative mortality will be recorded until day 30 post-op. | Up to day 30 post-op | |
| Secondary | Changes in Aerobic Capacity | Participants will perform a maximal CPET prior to beginning of intervention to establish baseline aerobic fitness. Upon completion of the intervention, prior to surgery, participants will repeat the maximal CPET. | 6 months | |
| Secondary | Length of stay | Length of stay will include general hospital stay from time of operation to discharge, ICU/HDU admission rates and length of stay as well as readmission rates. | 6 months | |
| Secondary | Postoperative complications assessed using the Postoperative Morbidity Survey | Postoperative morbidity will be assessed using the postoperative morbidity survey (POMS) (type and number of complications on a specific day). POMS will be performed on Day 3, 5, 6 and 7. | Up to 7 days post-op | |
| Secondary | Readmission rates | The amount of readmission's to hospital due to surgery related reasons. | 6 months | |
| Secondary | ICU/HDU admission rates | The amount of admissions to the Intensive Care Unit/High Dependency Unit due to surgery related reasons | 6 months | |
| Secondary | ICU/HDU length of stay | The amount of time (recorded in days) a patient spends in ICU/HDU due to surgery | 6 months | |
| Secondary | Clavien-Dindo Classification Sore | The most severe complication experienced by a patient will be assessed and recorded using the Clavien-Dindo Classification Score | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04552093 -
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)
|
Phase 2/Phase 3 | |
| Completed |
NCT04192565 -
A Prospective Investigation of the ColubrisMX ELS System
|
N/A | |
| Completed |
NCT05178745 -
A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
|
||
| Recruiting |
NCT03561350 -
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
|
||
| Recruiting |
NCT06128798 -
Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.
|
N/A | |
| Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
| Completed |
NCT03631407 -
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
|
Phase 2 | |
| Withdrawn |
NCT04192929 -
Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy
|
N/A | |
| Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
| Terminated |
NCT02842580 -
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
|
Phase 2 | |
| Completed |
NCT02889679 -
Underwater Resection of Non-pedunculated Colorectal Lesions
|
N/A | |
| Completed |
NCT02564835 -
Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
|
N/A | |
| Completed |
NCT02149108 -
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
|
Phase 3 | |
| Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
| Completed |
NCT02599103 -
The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
|
N/A | |
| Completed |
NCT01719926 -
Phase I Platinum Based Chemotherapy Plus Indomethacin
|
Phase 1 | |
| Completed |
NCT01669109 -
Hatha Yoga for Patients With Colorectal Cancer
|
N/A | |
| Recruiting |
NCT01428752 -
Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer
|
N/A | |
| Completed |
NCT01978717 -
General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer
|
N/A | |
| Completed |
NCT01877018 -
Colorectal Cancer Screening in Primary Care
|
N/A |